Treatment Efficacy of a Dual Release of Aflibercept and Dexamethasone From a Single Hydrogel Drug Delivery System in a Rodent Model
The Combo-DDS shows the potential to eliminate the need for separate dosing regiments of anti-VEGF and corticosteroids for non-responders to anti-VEGF monotherapy.
Authors
- Katherine L. Lydon (ORCID: https://orcid.org/0000-0003-2593-9658)
- Leandro B. C. Teixeria
- Jennifer J. Kang‐Mieler (ORCID: https://orcid.org/0000-0002-2844-5066)
- William F. Mieler (ORCID: https://orcid.org/0000-0001-8048-2692)
- Kayla M. Rudeen
- Chryssa M. Maloney
Institutions
- Stevens Institute of Technology (US)
- University of Wisconsin–Madison (US)
- Illinois Institute of Technology (US)
- AbbVie (United States) (US)
- University of Illinois Chicago (US)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1167/tvst.14.6.31
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71
Funders
- National Institutes of Health